Nektar Therapeutics
Delayed Nasdaq - 07/20 10:00:00 pm
48.73USD
-0.71%
Upcoming events on NEKTAR THERAPEUTICS

- No events available -

Past events on NEKTAR THERAPEUTICS
06/26/18 | 08:00pmAnnual General Meeting
06/13/18 | 03:40pmWilliam Blair Growth Stock Conference
06/06/18 | 09:00pmJefferies Global Healthcare Conference
06/04/18 | 03:00pmAmerican Society of Clinical Oncology Meeting - Abstract #3085
Upcoming sector events for NEKTAR THERAPEUTICS

- No events available -

Past sector events for NEKTAR THERAPEUTICS

- No events available -

Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
308
249
24%

1 181
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-28,9
-88,0
67%

694
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-43,7
-81,3
46%

692
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-96,7
-119
19%

669
EPS
 $
Released
Forecast
Spread
-0,62
-0,76
19%

3,79
Announcement Date03/01/2018
Quarterly / Semiannualy publications
Quarterly resultsQ2
2018
Q3
2018 (e)
Sales
Million $
Released
Forecast
Spread
1 088
1 033
5,3%

26,0
Operating income (EBITDA)
Million $
Released
Forecast
Spread
976
911
7,1%

-92,4
Operating profit (EBIT)
Million $
Released
Forecast
Spread
974
912
6,7%

-97,1
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
971
893
8,7%

-103
EPS
 $
Released
Forecast
Spread
5,33
5,22
2,1%

-0,59
Announcement Date08/08/2018
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise